These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G). Morris CB, Cheng E, Thanawastien A, Cárdenas-Freytag L, Clements JD. Vaccine; 2000 Mar 17; 18(18):1944-51. PubMed ID: 10699345 [Abstract] [Full Text] [Related]
10. Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. Staats HF, Bradney CP, Gwinn WM, Jackson SS, Sempowski GD, Liao HX, Letvin NL, Haynes BF. J Immunol; 2001 Nov 01; 167(9):5386-94. PubMed ID: 11673557 [Abstract] [Full Text] [Related]
11. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Mahdavi M, Ebtekar M, Khorram Khorshid HR, Azadmanesh K, Hartoonian C, Hassan ZM. Immunol Lett; 2011 Oct 30; 140(1-2):14-20. PubMed ID: 21679728 [Abstract] [Full Text] [Related]
15. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). Smiley KL, McNeal MM, Basu M, Choi AH, Clements JD, Ward RL. J Virol; 2007 Apr 30; 81(8):3740-8. PubMed ID: 17251301 [Abstract] [Full Text] [Related]
16. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, Watkins DI, Allen TM, Sette A, Altman J, Woodward R, Markham PD, Clements JD, Franchini G, Strober W, Berzofsky JA. Nat Med; 2001 Dec 30; 7(12):1320-6. PubMed ID: 11726972 [Abstract] [Full Text] [Related]